Novel Coronavirus Information Center

Elsevier’s free health and medical research on the novel coronavirus (SARS-CoV-2) and COVID-19

January 27, 2020 - Updated October 30, 2020

中文资源 (Chinese-language resources)

3D illustration of Coronavirus (© istock.com/Dr_Microbe)

Welcome to Elsevier's Novel Coronavirus Information Center. Here you will find expert, curated information for the research and health community on SARS-CoV-2 (the novel coronavirus) and COVID-19 (the disease).

All resources are free to access and include guidelines for clinicians and patients.

See our directory of all Elsevier's COVID-19 resources

For researchers

Under the Research tab, you will find the latest early-stage and peer-reviewed research on COVID-19 from journals including The Lancet and Cell Press. We have also made related articles and book chapters free to access on ScienceDirect.

View free articles on ScienceDirect

These articles are also available to download over FTP with rights for full text and data mining, re-use and analyses for as long as needed.

Server address: coronacontent.np.elsst.com
Protocol: sftp (SSH File Transfer Protocol)
Username: public
Password: beat_corona

You will need to use FTP client software such as Cyberduck or WinSCP to access the FTP server.

Download full text for data mining

We are also giving free access to Elsevier's clinical, biomedical and life sciences research resources and solutions to researchers focused on coronavirus drugs and vaccines or clinical research.

Gain free access to Elsevier biomedical tools

For clinicians

Under the Clinical information tab, you will find evidence-based skill guides and care plans for treatment, safety and patient education, along with emergency prepared webinars by the CDC.

For patients

In the Patient resources section, you can find our 3D4Medical coronavirus video, resources from the CDC and WHO, and information about Elsevier's Patient Access Program for research.

Share your feedback to help us improve our Novel Coronavirus Information Center. And if you experience any accessibility problems with the site or content, please contact accessibility@elsevier.com.

Introduction

Margaret Trexler Hessen, MD, Director, Point of Care, Elsevier

As the end of 2020 approaches, the pandemic marches on. SARS-CoV-2 is a virus of many tricks, and we have seen severe pneumonia, cytokine storm, macro- and microthrombotic disease, and Kawasaki-like systemic inflammatory syndrome in children (and recently in adults). When we began this information center in January, we anticipated “an explosion of clinical and epidemiological information and research,” and we have certainly seen that. Our goal was to open whatever resources we could to help public health authorities, researchers and clinicians contain and manage this disease. We have provided — and continue to provide — regularly updated resources from Elsevier's content and experts. Our resources span scientific and medical journals, educational products, a clinically focused COVID-19 Healthcare Hub and periodic podcast interviews with internationally-recognized experts. There is a new R&D tool, and we have created an interactive global map of experts based on Scopus data.

Clinical information

In this section, you can find the following resources:

Guidelines: including new NIH and NICE guidelines; COVID-19 guidance on testing, drug therapy, ventilators, PPE, cardiovascular medicine and anesthesiology; and videos on medical procedures.
Elsevier Clinical Solutions: Clinical Overviews on ClinicalKey, Clinical Skills for Nursing, Interprofessional Care Plans and patient engagement resources
Mental and behavioral health: Guidance for anxiety and depression, including Patient Engagement videos

Elsevier COVID-19 Healthcare Hub

Gain access to our latest evidence-based practices and resources for COVID-19, covering topics from symptom management to diagnosis, treatment and ongoing wellness.

Podcast series

Expert Insights on COVID-19 with Elsevier

In Elsevier's podcast series for frontline clinicians and providers, experts share their insights into the mode of transmission and pathophysiology of the virus, how medical informatics and telemedicine are used to manage the pandemic, and best practices for emergency nursing crisis preparedness.

Listen to the podcasts

Episode 9. SARS-CoV-2 Infection: Transmissibility, Pathophysiology and treatment

Episode 8. Emergency Nursing Best Practices and Standards of Patient Care

Episode 7: Treatment Options for COVID-19 features Jovan Borjan, PharmD, BCIDP, Clinical Pharmacy Specialist in Infectious Diseases at University of Texas MD Anderson Cancer Center, and host Dale Whitby, PharmD, Editor-in-Chief of Drug Information for Elsevier. They discuss a wide range of treatment options for COVID-19 and what we currently know based on studies. Discussion includes therapies with proposed antiviral activity, use of convalescent plasma, and agents being used to address cytokine storm. They also touch on use of anticoagulants, nutritional support, and other supportive care measures.

Episode 6: Pulmonary Aspects of COVID-19 Disease: Clinical Course, Ventilation and Related Issues features Esther Barreiro Portela, MD, PhD, Associate Professor, Pompeu Fabra University, Hospital del Mar Respiratory Medicine Department, Hospital del Mar Medical Research Institute (IMIM), Barcelona. With host Margaret Trexler Hessen, MD, Director, Point of Care, for Elsevier, Dr. Barreiro discusses the pulmonary aspects of COVID-19, such as clinical course and pathophysiology of lung involvement, noninvasive vs. mechanical ventilation based on observed phenotypes, and myocardial dysfunction, coagulopathy and other issues relating to the pathophysiology and critical care of these patients.

Episode 5: Biomedical Ethics During COVID-19 Pandemic, Part 2: Triaging Care, Allocation of Equipment, and Protecting the Providers features Prof. Don Postema, PhD, Program Director of Medical Ethics, HealthPartners, Center for Bioethics, University of Minnesota, and host Dr. Julibeth Lauren, PhD, APRN, ACNS-BC, VP, Editor-in-Chief, Nursing and Allied Health Practice and Patient Education at Elsevier. They discuss issues arising with patients and families, including restrictions on inpatient visiting, end-of-life issues, and how patients and families can obtain support from hospital biomedical ethics teams.

Episode 4: Biomedical Ethics During COVID-19 Pandemic: Part 1: Supporting Patients and Families in Times of Crisis features Prof. Don Postema, PhD, Program Director of Medical Ethics, HealthPartners, Center for Bioethics, University of Minnesota, and host Dr. Julibeth Lauren, PhD, APRN, ACNS-BC, VP, Editor-in-Chief, Nursing and Allied Health Practice and Patient Education at Elsevier. They discuss issues arising with patients and families, including restrictions on inpatient visiting, end-of-life issues, and how patients and families can obtain support from hospital biomedical ethics teams.

Episode 3: Medical Informatics and COVID-19: Role and Utility of Hospital Digital Resources and Telemedicine in Managing the Pandemic features Dr. Rebecca G. Mishuris, MD, Associate Chief Medical Information Officer at Boston Medical Center and Assistant Professor of Medicine at the Boston University School of Medicine. In this episode, Dr. Mishuris highlights the current state of EHR use to identify and track patients on the population level, advising and alerting patients, the role of telemedicine, and communication between providers and hospitals. The host is Dr. Sandy Falk, MD, Executive Editor-in-Chief, Clinical Practice Content at Elsevier.

Episode 2: COVID-19 and Emergency Preparedness: Emergency Nursing Best Practices and Standards of Patient Care features Dr. Daniel Nadworny, DNP, RN, Director of Emergency and Patient Care Services at Beth Israel Deaconess Milton Hospital in Massachusetts. Dr. Nadworny, an expert on emergency crisis preparedness, discusses best practices and standards of care regarding isolations, triage, testing, the changing dynamic of PPE, and supporting patients, families and staff in the current crisis. The host is Dr. Julibeth Lauren, PhD, APRN, ACNS-BC, VP, Editor-in-Chief, Nursing and Allied Health Practice and Patient Education at Elsevier.

Episode 1: The Path to a Timely, Safe and Effective COVID-19 Vaccine: Transmisibility, Pathophysiology and Treatment features Dr. Stanley Perlman, MD, PhD, Professor of Microbiology and Immunology and Professor of Pediatrics at the University of Iowa Hospitals and Clinics. Dr. Perlman, who has studied coronaviruses for 4 decades, discusses mode of transmission of SARS-CoV-2 during asymptomatic and presymptomatic state, pathophysiology and disease progression, and touches on treatment options and vaccine development. He is interviewed by Margaret Trexler Hessen, MD, Director, Point of Care, for Elsevier.

Webinar: COVID-19 — global perspectives and the transformation of US healthcare

In this free webinar, hosted by the Editorial Team of Healthcare: The Journal of Delivery Science and Innovation, two experts examine how COVID-19 is changing healthcare around the world. Dr. Ashish Jha looks at lessons learned from other countries and how they inform our approach to managing this and future pandemics. Bryony Winn discusses how lessons learned from COVID will influence US healthcare delivery for years to come. Register here

Guidelines

Guidelines for clinical practice, lab testing, equipment and more

New NIH treatment guidelines. A panel of US physicians, statisticians and other experts has developed treatment guidelines for COVID-19 intended for healthcare providers (read the press release).
COVID-19 Rapid Guidelines from NICE (via ClinicalKey)
Guidance for healthcare professionals (CDC)

Elsevier Clinical Solutions

Guidance from ClinicalKey, Clinical Solutions Nursing, Interprofessional Practice and Patient Education

Clinical Overviews on ClinicalKey are easy-to-scan clinically focused medical topic summaries designed to match the clinician workflow. Elsevier's Point-of-Care Editorial team develops them through a process that includes review and revision by a medical editor; peer reviews performed by subject matter experts; a production review to ensure consistency in style, grammar, and punctuation; and a final evaluation by the editor-in-chief.

Multisystem inflammatory syndrome in children (MIS-C) (Oct 21, 2020)
COVID-19 critical care (Updated Oct 21, 2020)
COVID-19 infection (Updated Oct 21, 2020)

Mental and behavioral health

With the fear and uncertainty brought on by the pandemic — and calls for social distancing — many people are experiencing increased stress, anxiety and depression. Our evidence-based patient education resources support professional practice guidelines, presenting information in a way that is easy to understand and actionable. You can find more resources in Elsevier's COVID-19 Healthcare Hub.

Anxiety resources

Anxiety screening tool

Elsevier has created this anxiety screening tool as part of our COVID-19 resources for patients, clinicians and the public. It's designed for individuals age 13 years and older. For all others, please talk to your healthcare team about you or your child’s questions and concerns.

Clinical Skills

Clinical Overviews

Generalized Anxiety Disorder

Interprofessional Care Planning

Clinical eLearning

Caring for the patient with General Anxiety Disorder

Patient Education

Anxiety literature

Book chapters and peer-reviewed articles from Elsevier journals

Anxiety Disorders, Chapter 24, Stress: Concepts, Cognition, Emotion, and Behavior: Handbook in Stress Series, Volume 1 (Academic Press, 2016)
Fatigue and Stress, Chapter 42, Concepts, Cognition, Emotion, and Behavior (Academic Press, 2016)
Exercise for the Management of Anxiety and Stress-Related Disorders, Chapter 2, Exercise-Based Interventions for Mental Illness (Academic Press, 2018)
Anxiety (Generalized Anxiety Disorder), Ferri's Clinical Advisor (Elsevier, 2020)

Depression resources

Depression screening tool

Elsevier has created this depression screening tool as part of our COVID-19 resources for patients, clinicians and the public. It's designed for individuals age 18 years and older. For all others, please talk to your healthcare team about you or your child’s questions and concerns.

Clinical Skills

Clinical Overviews

Major Depressive Disorder

Patient Education

Depression literature

Book chapters and peer-reviewed articles from Elsevier journals

Novac, Andrei, MD: Depressive, Bipolar, and Related Mood Disorders, Conn's Current Therapy (Elsevier, 2020 )
Zimmerman M, D’Avanzato C: Major Depression, Ferri's Clinical Advisor (Elsevier, 2020)

Journal articles

The role of social integration in the adverse effect of unemployment on mental health – Testing the causal pathway and buffering hypotheses using panel data, Social Science Research (Feb 2020)
The psychological impact of quarantine and how to reduce it: rapid review of the evidence, The Lancet (March 2020)
Suicidal thoughts and behaviors and social isolation: A narrative review of the literature, Journal of Affective Disorders (Feb 2019)

Physician engagement: mindfulness as part of the pandemic solution

Frank John Ninivaggi, MD

May 21, 2020

Clinical insight

COVID-19 and loneliness: Can we do anything about it?

Ami Rokach, PhD

May 22, 2020

Clinical insight

6 evidence-based methods to head off COVID-19-related depression and anxiety

Elisa M Brietzke, MD

May 27, 2020

Video: How Fangcang Shelter Hospitals function in combating COVID-19

With Chen Wang, MD, PhD, FCCP, President of the Chinese Academy of Medical Sciences | April 1, 2020

When Wuhan faced a surge of COVID-19 patients, they couldn’t all be admitted to hospitals, and high infection risk threatened the lives of health workers. That same situation is now occurring around the world.

Chinese-language resources

中文资源

Resources from Elsevier's Clinical Solutions team in China

Date	Title	Published by (CN)	Published by (EN)	Link
	Virology 病毒学
1月24日	新型冠状病毒国家科技资源服务系统。共享： 1）第一株病毒毒种信息及其电镜照片 2）新型冠状病毒核酸检测引物和探针序列	国家微生物科学数据中心和国家病原微生物资源库	National Microbiological Data Center; National Pathogen Resource Collection Center	http://nmdc.cn/#/nCoV

View more resources

	Diagnosis & Treatment Guidelines 诊疗指南
5月8日	做好新冠肺炎疫情常态化防控工作的指导意见	国务院	State Council	http://www.nhc.gov.cn/xcs/zhengcwj/202005/4d6106406d274bc69b30e4fb61150ced.shtml
4月16日	新冠肺炎疫情社区防控与服务工作精准化精细化指导方案	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202004/7838c406600d4d38a11f5675c98a2ecf.shtml
4月14日	大专院校新冠肺炎疫情防控技术方案	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202004/7838c406600d4d38a11f5675c98a2ecf.shtml
4月13日	Guidelines for Investigation and Management of Close Contacts of COVID-19 Cases	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://weekly.chinacdc.cn/en/article/id/aa16e57b-d717-40f0-bf34-265c6e011508
4月13日	Technical Guidelines for COVID-19 Laboratory Testing	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://weekly.chinacdc.cn/en/article/id/0f6dc581-08f4-4828-97f0-9cc805969bbb
Chinese Center for Disease Control and Prevention	Guidelines for Personal Protection of Specific Groups from COVID-19	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://weekly.chinacdc.cn/en/article/id/65577621-f02e-4c47-b883-f70659c300b3
4月13日	Technical Guidelines for Disinfection of Special Sites for COVID-19	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://weekly.chinacdc.cn/en/article/id/7120f4f9-e03d-4164-9bf2-3e097d4b3734
4月11日	Protocol for the Management of Asymptomatic Persons Infected with COVID-19 Virus	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://weekly.chinacdc.cn/en/article/id/18987f85-feb8-44c8-b94e-8bdcd8ad141a
4月8日	新冠病毒无症状感染者管理规范	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202004/9d3edaaebb9a4c369f42c61039be35fe.shtml
4月8日	新冠肺炎出院患者复诊复检工作方案（试行）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202004/1ba91504225040a7ac2c9eda48cc4e7e.shtml
4月1日	新型冠状病毒肺炎重型、危重型病例诊疗方案（试行第二版）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202004/c083f2b0e7eb4036a59be419374ea89a.shtml
3月29日	Diagnosis and Treatment Protocol for COVID-19 (Trial Version 7)	国家卫生健康委员会	National Health Commission	http://en.nhc.gov.cn/2020-03/29/c_78469.htm
3月19日	Guidelines for COVID-19 Epidemiological Investigations	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://weekly.chinacdc.cn/en/article/id/99b0a945-a516-410a-9260-7db46e792877
3月15日	Guidelines for Investigation and Management of Close Contacts of COVID-19 Cases	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://weekly.chinacdc.cn/en/article/id/aa16e57b-d717-40f0-bf34-265c6e011508
3月13日	Technical Guidelines for COVID-19 Laboratory Testing	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://weekly.chinacdc.cn/en/article/id/0f6dc581-08f4-4828-97f0-9cc805969bbb
3月13日	Guidelines for Personal Protection of Specific Groups from COVID-19	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://weekly.chinacdc.cn/en/article/id/65577621-f02e-4c47-b883-f70659c300b3
3月13日	Technical Guidelines for Disinfection of Special Sites for COVID-19	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://weekly.chinacdc.cn/en/article/id/7120f4f9-e03d-4164-9bf2-3e097d4b3734
3月13日	新冠肺炎出院患者健康管理方案（试行）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202003/056b2ce9e13142e6a70ec08ef970f1e8.shtml
3月12日	重症新型冠状病毒肺炎管理专家推荐意见	中华医学会	Chinese Medical Association	https://www.cma.org.cn/art/2020/3/12/art_2928_33535.html
3月12日	北京协和医院麻醉科手术室新冠肺炎（COVID-19）疫情期间区域分级防护规范（试行）	中华医学会	Chinese Medical Association	https://www.cma.org.cn/art/2020/3/12/art_2928_33535.html
3月11日	Protocol for Prevention and Control of COVID-19 (Edition 6)	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://weekly.chinacdc.cn/en/article/id/e97a6f76-c07f-4d43-bd73-51067a4fc9f9
3月7日	新型冠状病毒肺炎防控方案（第六版）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202003/4856d5b0458141fa9f376853224d41d7.shtml
3月4日	新型冠状病毒肺炎诊疗方案（试行第七版）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml
2月26日	新型冠状病毒肺炎（NCP）床旁超声心动图检查及远程超声诊断实施方案（第一版）	中华医学会	Chinese Medical Association	https://www.cma.org.cn/art/2020/2/26/art_2928_33048.html
2月24日	新型冠状病毒肺炎重型、危重型病例诊疗方案（试行第二版）	中华医学会	Chinese Medical Association	https://www.cma.org.cn/art/2020/2/24/art_2928_32959.html
2月21日	新型冠状病毒肺炎防控方案（第五版）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202002/a5d6f7b8c48c451c87dba14889b30147.shtml
2月19日	新型冠状病毒肺炎诊疗方案（试行第六版）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202002/8334a8326dd94d329df351d7da8aefc2.shtml
2月17日	新型冠状病毒肺炎疫情防控期间养老机构老年人就医指南	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202002/c26a0ca4a58d47489c5781493b2ac624.shtml
2月14日	新型冠状病毒感染相关ICD代码	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202002/dcf3333b740f4fabad5f9f908d1fc5b4.shtml
2月8日	新型冠状病毒肺炎诊疗方案（试行第五版修正版）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202002/d4b895337e19445f8d728fcaf1e3e13a.shtml
2月7日	新型冠状病毒感染的肺炎防控方案（第四版）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202002/573340613ab243b3a7f61df260551dd4.shtml
2月5日	新型冠状病毒感染的肺炎诊疗方案（试行第五版）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202002/3b09b894ac9b4204a79db5b8912d4440.shtml
2月1日	新型冠状病毒感染的肺炎患者遗体处置工作指引（试行）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/yzygj/s7659/202002/163c26a24057489dbf64dba359c59a5f.shtml
1月28日	新型冠状病毒感染的肺炎防控方案（第三版）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202001/470b128513fe46f086d79667db9f76a5.shtml
1月28日	新型冠状病毒感染的肺炎病例转运工作方案（试行）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202001/ccee6ec0942a42a18df8e5ce6329b6f5.shtml
1月27日	新型冠状病毒感染的肺炎诊疗方案（试行第四版）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202001/4294563ed35b43209b31739bd0785e67.shtml
1月25日	关于“新型冠状病毒感染的肺炎”诊疗建议方案（V2.0）	中国医学科学院北京协和医院	Peking Union Medical College Hospital, CAMS	https://new.qq.com/omn/HLH20200/HLH2020012501009300.html
1月24日	《新型冠状病毒肺炎诊疗快速指南》	华中科技大学同济医学院附属同济医院专家组	Tongji Hospital, Tongji Medical College of HUST	https://xw.qq.com/health/20200124010910/HLH2020012401091000
1月24日	《武汉协和医院处置2019新型冠状病毒感染策略及说明》	华中科技大学同济医学院附属协和医院专家组	Xiehe Hospital, Tongji Medical College of HUST	https://www.dxy.cn/bbs/newweb/pc/post/42662254
1月23日	湖北省新型冠状病毒感染的肺炎诊疗方案(试行第一版）	湖北省医疗救治专家组	Medical Expert Panel of Hubei Province	https://xw.qq.com/cmsid/20200123A0KNOW00
1月23日	医疗机构内新型冠状病毒感染预防与控制技术指南（第一版）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202001/b91fdab7c304431eb082d67847d27e14.shtml
1月23日	新型冠状病毒实验室生物安全指南（第二版）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/xcs/zhengcwj/202001/0909555408d842a58828611dde2e6a26.shtml
1月22日	新型冠状病毒感染的肺炎诊疗方案（试行第三版）（PDF可下载）	国家卫生健康委员会	National Health Commission	http://www.nhc.gov.cn/yzygj/s7653p/202001/f492c9153ea9437bb587ce2ffcbee1fa.shtml
	Epidemic situation 疫情分布
Daily update	新型冠状病毒感染的肺炎疫情分布	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://2019ncov.chinacdc.cn/2019-nCoV/
	Research articles 研究进展和经典图书
4月30日	Nursing Management in General Hospitals during the Prevention and Control of COVID-19	北京大学医学出版社	Peking University Medical Press	http://cdn.pumpedu.com.cn/pdfview/index.php?cc=21650en
4月30日	Handbook of Common Nursing Technology for COVID-19	北京大学医学出版社	Peking University Medical Press	http://cdn.pumpedu.com.cn/pdfview/index.php?cc=21667en
4月30日	Specialty Issues in the Management and Treatment of COVID-19	北京大学医学出版社	Peking University Medical Press	http://cdn.pumpedu.com.cn/pdfview/index.php?cc=21634en
4月19日	Handbook of Basic Epidemiological Knowledge on Coronavirus Disease 2019(COVID-19)-110 Questions & Answers	北京大学医学出版社	Peking University Medical Press	https://mp.weixin.qq.com/s/FCegqoxc5X72uqdsulzc1A
4月19日	《新型冠状病毒肺炎流行病学知识110问》	北京大学医学出版社	Peking University Medical Press	https://mp.weixin.qq.com/s/zkPzfFLuPDdymj0od4eUHw
4月2日	COVID-19 Academic Research Communication Platform (English) - Free to read	中华医学会杂志社	CMA Publishing House	http://medjournals.cn/COVID-19/index.do
4月2日	新型冠状病毒肺炎科研成果学术交流平台（中文）- 免费阅读	中华医学会杂志社	CMA Publishing House	http://medjournals.cn/2019NCP/index.do
2月28日	COVID-19影像表现及研究进展	中华医学会放射学分会青年委员会	Youth Committee, Radiology Branch of Chinese Medical Association	https://mp.weixin.qq.com/s/MnJyIzobbDQdicAQScG1ow
2月18日	A strategy to prevent future epidemics similar to the 2019-nCoV outbreak	Biosafety and Health	Biosafety and Health	https://www.sciencedirect.com/science/article/pii/S2590053620300161
2月18日	Technical guidance for laboratory testing of 2019-nCoV infection (third edition)	Biosafety and Health	Biosafety and Health	https://www.sciencedirect.com/science/article/pii/S2590053620300136
2月18日	Laboratory biosafety guide for the novel coronavirus	Biosafety and Health	Biosafety and Health	https://www.sciencedirect.com/science/article/pii/S2590053620300136
1月25日	中国新型冠状病毒感染病例首批临床数据报告（解读, with link to sourse articles）	The Lancet Weichat Official Account	The Lancet Weichat Official Account
1月22日	Notes from the Field: An Outbreak of NCIP (2019-nCoV) Infection in China — Wuhan, Hubei Province...[2020-01-22]	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://weekly.chinacdc.cn/en/article/id/e3c63ca9-dedb-4fb6-9c1c-d057adb77b57
1月21日	A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases — Wuhan, China 2019-2020[2020-01-21]	中国疾病预防控制中心	Chinese Center for Disease Control and Prevention	http://weekly.chinacdc.cn/en/article/id/a3907201-f64f-4154-a19e-4253b453d10c
1月21日	引自《默里及纳达尔呼吸医学》，V Courtney Broaddus 主编，李为民、程德云主译，人民卫生出版社，2018	李为民、程德云主译，人民卫生出版社，2018	Elsevier, with content quoted from translation published by PMPH	Influenza Pneumonia Coronavirus
	Patient Education 患者教育
2020.1.24	轻症疑似2019新型冠状病毒患者及密切接触人员如何进行自我管理	北京协和医院呼吸科	Respiratory Department, Peking Union Medical College Hospital, CAMS	http://m.sohu.com/a/368777653_102327

临床综述：冠状病毒：新型冠状病毒（COVID-19）感染

临床综述是按照专科和疾病开发的的简明诊断治疗内容，帮助医生在临床工作中遇到问题时快速获取答案。

爱思唯尔专业临床内容编辑团队负责临床综述的开发，医学编辑进行最初的审查和修改，再由专科领域的专家进行同行审核。生产编辑负责确保风格、语法和标点符号的一致性。最终由主编审核通过后发布。

冠状病毒：新型冠状病毒（COVID-19）感染

3D4Medical 视频揭示新冠病毒从传播到入侵的全过程

3D4Medical的旗舰平台Complete Anatomy，是世界上最先进的解剖学平台。2019年注册用户超过了120万，有超过2500万的下载量，在160个国家的苹果、微软和谷歌的应用商店中被选为排名第一的医疗应用。

全球冠状病毒研究机构及研究人员分布图

基于爱思唯尔独有的全球最大的引文摘要数据库Scopus，聚焦冠状病毒疫情爆发及疫情控制研究。通过关键词检索分析，得到了自1996年至今已发表的22000多篇文献。在科研表现世界地图中，展示了全球表现突出的500多所科研机构（发文量超过10篇含）。其中，中国的科研机构有200多所。在这200多所中国科研机构中，中国大陆有150所，中国香港有15所，中国台湾有43所。

中国的科研机构按照发文量来看，香港大学以2888篇占据首位，远远高于排在第二位的香港中文大学（1766篇），中国农科院以1519篇论文紧随其后。其他占据发文前十的科研机构还包括中国医学科学院、国立台湾大学、中科院微生物所、中国疾病预防控制中心、北京大学、华中农业大学和首都医科大学。除此之外，复旦大学、中国军事医学科学院、清华大学、华南农业大学、中山大学、中科院武汉病毒所也分别发表了超过400篇的相关科研论文。

通过互动地图，不仅可以概览全球特别是中国的相关研究机构分布，同时还可以通过放大或缩小地图来聚焦某个研究机构，靶定该机构的研究人员来进行深入分析，以获取更多有价值的信息。

注：按照发文量进行排名，地图中蓝色标记的为全球冠状病毒研究排名前500的机构，红色标记为中国排名前200的机构，紫色标记为排在全球前500机构中的中国机构。

Because Google is not available in China and various other countries, we are offering a local version of the map, enabling you also to download the data.

View the interactive version on Baidu

爱思唯尔数据揭示全球传染病研究趋势

在过去的二十年里，世界爆发了几次传染病疫情。爱思唯尔通过1996年至2018年的SciVal和Scopus数据，来分析学术成果、趋势主题和顶级研究机构的工作，进一步增进我们对传染病疫情及应对方式的了解。

下载《传染病疫情研究：见解和趋势》报告

全球冠状病毒研究机构及研究人员分布图

基于爱思唯尔独有的全球最大的引文摘要数据库Scopus

Research

In this section, you can find the following resources:

Journal articles, including coronavirus hubs by The Lancet and Cell Press
Early-stage research (preprints on SSRN)
Infographic: global research trends in infectious disease
Interactive map: global disease outbreak experts

The Lancet Coronavirus Hub

The Lancet's Coronavirus hub page brings together new coronavirus content from The Lancet journals as it is published.

Cell Press Coronavirus Resource Hub

On this Coronavirus Resource Hub, curated by members of the Cell Press editorial team, you'll find content about the outbreak as it appears in Cell Press journals along with our policies for submitting papers.

1Science Coronavirus Research Repository

1science, acquired by Elsevier in 2018, was created to expand the scope of existing abstracting and analytics databases. It includes quality controlled academic and research documents in all disciplines and languages, from all countries. Its core index, 1findr, currently comprises more than 120 million metadata records, including over 30 million links to free full-text articles selected from about 100,000 referred scholarly journals. The Coronavirus Research Repository is a custom extraction from 1findr comprising articles on COVID-19, MERS, SARS and coronaviruses in general.

Centre d’information sur le nouveau coronavirus

This French version of our Novel Coronavirus Information Center includes regular updates on research in French journals.

Call for papers

Various Elsevier journals have special issues related to COVID-19

MethodsX special issue on Pandemics and their impacts on global economic and financial systems. This special issue will focus on descriptions of methods for economics and finance researchers that can be used to study not only COVID-19 but any pandemic for that matter.

The Journal of Molecular Diagnostics seeks manuscripts related to SARS-CoV-2. The Journal of Molecular Diagnostics — the official journal of the Association for Molecular Pathology (AMP) — is calling for manuscripts that display new or improved molecular methods which may be applied to diagnosis or monitoring of SARS-CoV-2. Accepted manuscripts will be expedited through the publication process as much as possible and will be free through Elsevier’s Novel Coronavirus Information Center and ScienceDirect. Please refer to the guide for authors for information on submission.
American Journal of Pathology seeks manuscripts related to SARS-CoV-2. The American Journal of Pathology — the official journal of the American Society for Investigative Pathology — is calling for manuscripts that address mechanisms of SARS-CoV-2 pathogenesis or provide a foundation for future mechanistic inquiries. Accepted manuscripts will be expedited through the publication process as much as possible and will be free to access through Elsevier’s Novel Coronavirus Information Center and ScienceDirect. Please refer to the guide for authors for information on submission.
Medical Mycology Case Reports special Issue: COVID-19 associated pulmonary aspergillosis (CAPA). The high number of personal observations shared by clinicians who have been taking care of patients with invasive pulmonary aspergillosis as a complication of severe COVID-19 disease and first reports indicating that up to 30 percent of those patients have signs of Aspergillus co-infections is alarming.This special issue aims to bring together clinical experience in the management of patients with CAPA presented as individual case reports or small case series.
Chaos, Solitons & Fractals Special Issue: Modeling and forecasting of epidemic spreading: the case of Covid-19 and beyond. The editors write: "[There] is a pressing and immediate need for the scientific community to come together and provide novel and better methods, strategies, forecasting techniques and models to understand and mitigate the effects of this and future pandemics. ..."
Mathematical Biosciences Virtual Special Issue: Transmission dynamics and control of Novel Coronavirus SARS-CoV-2. This virtual issue welcomes contributions on the use of mathematical, statistical and computational modeling approaches for providing deeper mechanistic insights into the transmission dynamics and control of SARS-CoV-2.
Open-source journal HardwareX calls for COVID-19 equipment designs. Papers will be free to publish and free to read.

Content hubs from other publishers

Elsevier is among various publishers who are making relevant papers freely available. Others include: Springer Nature | Wiley | NEJM | BMJ | American Society for Microbiology | American College of Cardiology| Chongqing VIP Information. Many publishers have also signed the Wellcome Trust Statement committing to share relevant nCoV research and data rapidly and openly.

You can find all these publishers and more on LitCovid — the National Library of Medicine's curated hub of scientific literature about novel coronavirus. It currently provides access to more than 3,200 articles in PubMed and is being updated daily.

Early-stage research: preprints on SSRN

Rapidly evolving healthcare emergencies necessitate the quick dissemination of research. The growing role of preprints, or early-stage research, was acknowledged in the Ebola and Zika virus outbreaks as a way of “accelerating the dissemination of scientific findings to support responses to infectious disease outbreaks.” SSRN , Elsevier’s platform for the rapid worldwide dissemination of early-stage research, is committed to making authors' coronavirus related research available immediately. Research on SSRN is free to download and upload. It is important to note that these papers have not benefited from the pivotal role of the peer-review process, which validates and improves the quality of final published journal articles.

View coronavirus research on SSRN

Top 10 SSRN downloads of the week*

* Calculated on Friday, Oct. 30

Infographic: Global research trends

Infographic outbreak research top institutions map

Infographic: global research trends in infectious disease

Download Elsevier’s infographic on infectious disease research trends, top research orgs and the impact of outbreaks

The Elsevier Community

March 25, 2020 2 mins

Interactive map: global coronavirus experts

This map represents the most active institutions researching COVID-19 and related coronaviruses. We ran a search in Scopus — a source-neutral abstract and citation database of over 75 million records — for publications related to COVID-19, coronaviruses and related diseases such as SARS and MERS. We then used the resulting ~28,000 publications to identify the currently active researchers and institutions that are working in these areas, the map shows the most prolific global institutions and links to their authors. (Updated: October 29, 2020)

Click on a pin to see more about the institution, the numbers of researchers and their publications that matched our query in Scopus. Then link through to the researcher's profiles in Scopus to learn more about their areas of expertise.

Vaccines and drug discovery

Information on vaccines coming soon. This section will include:

Drug monographs
Clinical guidance
Patient Education documents

You can search for vaccine studies in our Research section.

Free access to biomedical tools via Elsevier's Coronavirus Research Hub

Elsevier is offering researchers free access to a collection of clinical, biomedical and life sciences research resources and solutions for coronavirus research through October 28, 2020. These may be used by academic, government, not-for-profit and commercial researchers. We will initially give priority to researchers working on vaccine, drug and clinical research while working to increase the capacity of the platform for further use cases. The Hub includes access to ClinicalKey, Embase, SSRN, Mendeley Data, the ScienceDirect Covid-19 collection, Elsevier Text Mining (ETM), Mendeley and the Pure Covid-19 Portal. We plan to bring Reaxys and Veridata EDC online shortly. Visit Elsevier's Coronavirus Research Hub

R&D tool to capture clinical trial data is free for researchers studying COVID-19

Elsevier recently launched Veridata Electronic Data Capture (EDC), which enables clinical researchers to capture clinical trial data in a secure environment. To assist researchers working to develop vaccines and other therapies for COVID-19, Elsevier has pledged to make Veridata EDC available for free. Interested clinical researchers can contact Elsevier customer support via e-mail at covid19@elsevier.com and apply for a demo account. Following the necessary compliance training, they will receive a free 12-month license. Read the press release

Gender and COVID-19 Group on Mendeley

This collection of research, studies and other references covers the sex and gender dimensions of the COVID-19 pandemic, caused by the SARS-CoV-2 coronavirus. The library is a public group, free for anyone in the world to join, access and add. References - articles, preprints, news articles, blog posts, magazine articles, reports, etc - include those compiled by Dr. Rosemary Morgan at Johns Hopkins University and colleagues from the Gender and COVID-19 Working Group, as well as those from other compilations and sources. The library on the Mendeley platform includes >500 references related to Gender and COVID-19, as well as gender and other infectious disease/epidemics, which you can locate and find resources, include direct citations and references within your work, and add additional references & folders directly to the group. We invite the community to continue posting new references as they’re published/become available even if also being added to an existing compilation elsewhere.

COVID-19 drug therapy — updated on October 26

Pharmacists in Elsevier's Clinical Solutions group write about potential treatment options for COVID-19. Read their paper.

Drug information from Elsevier's R&D Solutions

Elsevier's R&D solutions for pharma and life sciences integrate data, analytics and technology to help researchers make data-driven drug discovery and development decisions and streamline literature monitoring for pharmacovigilance. Here, we use those tools to generate information relevant to combating COVID-19:

121 drugs and natural products successfully used against previous coronavirus infections including SARS. This list was generated using Elsevier's Pathway Studio.
393 substances that interact with 25 targets related to 6 target species including SARS coronavirus, Middle East respiratory syndrome coronavirus, human Middle East respiratory syndrome coronavirus, Human coronavirus 229E, Coronaviridae and Coronavirinae, with normalized affinity value > 6. This list was generated using Elsevier’s Reaxys Medicinal Chemistry.
Autophagy is a cellular recycling process, whereby cells eliminate damaged or diseased components in order to regenerate and build new healthier cells; thus, viruses are usually identified and disposed of in this way. Would it be possible to induce the autophagy process and limit the viral infection by using some substances? Pathway Studio provides a list of 406 compounds that have been reported inhibiting autophagy pathway, and their related references as well as a list of 802 compounds that have activating roles in autophagy.

Mayo Clinic Proceedings: Possible COVID-19 Pharmacotherapies and QTc/TdP Liability

The Mayo Clinic Proceedings journal has released a pre-proof of a new paper titled Possible COVID-19 Pharmacotherapies and QTc/TdP Liability. From the abstract: "As the COVID-19 global pandemic rages across the globe, the race to prevent and treat this deadly disease has led to the “off label” re-purposing of drugs such as hydroxychloroquine and lopinavir/ritonavir with the potential for unwanted QT interval prolongation, and a risk of drug induced sudden cardiac death. With the possibility that a significant proportion of the world’s population could receive soon COVID-19 pharmacotherapies with torsadogenic potential for therapy or post-exposure prophylaxis, this document serves to help healthcare providers mitigate the risk of drug-induced ventricular arrhythmias while minimizing risk to personnel of COVID 19 exposure and conserving the limited supply of personal protective equipment. Read the paper

Pure portal: Discover research collaborators and institutions globally

Use this Pure portal to discover novel coronavirus related research collaborators and institutions around the world. It uses Elsevier’s Natural Language Fingerprinting technology, scientific taxonomies and Scopus profiles and can be used to filter and find associated publications.

Additional information and examples

Public health

Here, you will find guidance and commentary from experts along with official guidance from major health organizations such as the CDC and WHO. For research on public health and related topics, see our Research section.

Available on demand: 14th Vaccine Congress Online Edition

The 14th Vaccine Congress – Online Edition: Combatting the threat of Covid-19 featured leading experts in vaccinology sharing their knowledge on the current developments and challenges we face. Sessions are now available free on demand. Register here

Dr. Fauci features Cell paper in Congressional hearing

Research insight

A serendipitous discovery advances COVID research – and makes a cameo in Congress

“This is work we really need to pursue,” Dr. Fauci says, touting findings that T cells from common coronaviruses may offer protection against COVID-19

Alison Bert, DMA

August 19, 2020

Studies to improve face masks and disinfect the air

In a new article in Materials Today Physics, researchers describe their air disinfection system to control the spread of COVID-19, for which they filed a provisional patent application: Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system (July 7, 2020)

In Open Ceramics, researchers describe a sputtered antimicrobial/virucidal silver nanoclusters/silica composite coating to significantly improve the protection capacity of face masks while also being suitable for coating air filters and other surfaces: Virucidal effect against Coronavirus SARS-CoV-2 of a silver nanocluster/silica composite sputtered coating (June 6, 2020)

Special issue: Bioaerosol and infectious diseases

This special issue in the Journal of Aerosol Science, from 2018, has articles that are relevant to COVID-19.

COVID-19 Pandemic Collection in AJPM

View this collection in the American Journal of Preventive Medicine

Articles in this COVID-19 Pandemic collection cover pressing public health issues, including vulnerable populations at risk and economic impact:

View the articles

COVID-19 Data Insights Map by LexisNexis Risk Solutions

By combining their data and analytics with those of other industry stakeholders, LexisNexis Health Care created a COVID-19 dataset and interactive visualization to provide insights on at-risk populations and care capacity risks. View the map

Progress in Disaster Science: COVID-19 Special Collection

Keeping wider disciplinary involvement in mind, the journal Progress in Disaster Science plans to publish special issues as a major learning from the evolving nature of the pandemic. Papers on the following topics related to COVID-19 response are encouraged: public health response, governance and policy analysis, emerging technologies, roles of civil societies and other stakeholders, citizen participation, collateral hazards, business continuity, recovery planning, economic/fiscal implications. Read the special collection

Journal of Aerosol Science: Special section on "Virus Aerosol Science, Sampling, and Control"

The editor, Prof. Chris Hogan, writes: "The Journal of Aerosol Science has long been a resource on understanding viruses in aerosols, methods to sample airborne viruses, and to control and inactivate airborne viruses. In this collection, we highlight numerous studies over the past decade focusing on virus aerosol science. In addition, we invite authors to contribute this virtual collection by submitting to this journal, selecting the option: "SARS-CoV-2 & Virus Aerosols." Read the special section

COVID-19 podcasts and webinars by CIDRAP

Relevant webinars and audio podcasts by subject matter experts compiled by the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota. Each focuses on a different area of interest. View the list here

More public health resources

Disaster Epidemiology and Surveillance, Chapter 27, Jekel's Epidemiology, Biostatistics, Preventive Medicine, and Public Health, 5th Edition (Elsevier, 2020)
Impacts on Society and Economy (OECD)
Interactive map showing global spread of COVID-19 (WHO)
Interactive map shows global spread of the virus (Johns Hopkins CSSE)
Guidance for businesses and employers (CDC)
Travel precautions (CDC)
Information and updates (CDC)
Novel coronavirus advice for the public (WHO)
Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: Interim Guidance (WHO)
National Genomic Data Center (China) 2019 nCoV Resource Center (新型冠状病毒信息库)

Official coronavirus guidance from various countries:

Patient resources

عدوى فيروس كورونا المستجد (patient education in Arabic)

عدوى فيروس كورونا المستجد

Elsevier's Patient Access Program for research

With our Patient Access Program, patients and their caregivers can receive medical or healthcare related research papers by emailing patientaccess@elsevier.com. This email is constantly monitored by our support teams, who aim to provide individual articles at no cost to patients and caregivers within 24 hours. Requesters simply need to include the article title and authors, date published, and/or the DOI or URL if available so we can locate the article as quickly as possible. Learn more

COVID-19 podcasts and webinars

More resources

Novel coronavirus advice for the public (WHO)
Travel precautions (CDC)
See our Patient Education resources under Mental & Behavioral Health

Usage notice

Since January 2020, Elsevier has created an online resource center with free information in English and Mandarin on the novel coronavirus (COVID-19).

This Novel Coronavirus Information Center is hosted on Elsevier Connect, the company’s public news and information website.

Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource center — including this research content — immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource center remains active.

Contributors

Written by

Elsevier Connect

Written by

Elsevier Connect

This site features daily stories for the global science, health and technology communities, written by experts in the field as well as Elsevier colleagues.

Novel Coronavirus Information Center

For researchers

For clinicians

For patients

Introduction

Margaret Trexler Hessen, MD, Director, Point of Care, Elsevier

Clinical information

Podcast series

Expert Insights on COVID-19 with Elsevier

Guidelines

Guidelines for clinical practice, lab testing, equipment and more

Physiotherapy guidelines

Guidelines for laboratories and testing

Drug therapy guidance

Ventilator recommendations

Use of personal protective equipment (PPE)

Cardiovasular guidance

More guidance for clinicians

NEJM videos on clinical medicine procedures

Elsevier Clinical Solutions

Guidance from ClinicalKey, Clinical Solutions Nursing, Interprofessional Practice and Patient Education

Clinical Skills for Nursing

Interprofessional Care Plans

Patient engagement resources

Mental and behavioral health

Anxiety resources

Clinical Skills

Clinical Overviews

Interprofessional Care Planning

Clinical eLearning

Patient Education

Anxiety literature

Book chapters and peer-reviewed articles from Elsevier journals

Journal articles

Depression resources

Clinical Skills

Clinical Overviews

Patient Education

Depression literature

Book chapters and peer-reviewed articles from Elsevier journals

Journal articles

Related stories by Elsevier book authors

Video: How Fangcang Shelter Hospitals function in combating COVID-19

With Chen Wang, MD, PhD, FCCP, President of the Chinese Academy of Medical Sciences | April 1, 2020

Chinese-language resources

中文资源

Resources from Elsevier's Clinical Solutions team in China

临床综述：冠状病毒：新型冠状病毒（COVID-19）感染

3D4Medical 视频揭示新冠病毒从传播到入侵的全过程

爱思唯尔数据揭示全球传染病研究趋势

全球冠状病毒研究机构及研究人员分布图

基于爱思唯尔独有的全球最大的引文摘要数据库Scopus

Research

Call for papers

Various Elsevier journals have special issues related to COVID-19

Content hubs from other publishers

Early-stage research: preprints on SSRN

Top 10 SSRN downloads of the week*

Infographic: Global research trends

Interactive map: global coronavirus experts

Vaccines and drug discovery

Free access to biomedical tools via Elsevier's Coronavirus Research Hub

R&D tool to capture clinical trial data is free for researchers studying COVID-19

Gender and COVID-19 Group on Mendeley

COVID-19 drug therapy — updated on October 26

Drug information from Elsevier's R&D Solutions

Mayo Clinic Proceedings: Possible COVID-19 Pharmacotherapies and QTc/TdP Liability

Pure portal: Discover research collaborators and institutions globally

Public health

Available on demand: 14th Vaccine Congress Online Edition

Dr. Fauci features Cell paper in Congressional hearing

Studies to improve face masks and disinfect the air

COVID-19 Pandemic Collection in AJPM

View this collection in the American Journal of Preventive Medicine

Progress in Disaster Science: COVID-19 Special Collection

Journal of Aerosol Science: Special section on "Virus Aerosol Science, Sampling, and Control"

COVID-19 podcasts and webinars by CIDRAP

More public health resources

Patient resources

Video overview of Coronavirus from 3D4Medical — Watch now: